| Investor Type | Firm |
| Stages | Series D, Series C, Series B |
| Investment Range | $73,900,000 - $600,000,000 |
TCG X is a healthcare investment firm dedicated to advancing disruptive medicines and supporting companies that can improve the lives of patients. TCG X invests in both private and public companies led by exceptional entrepreneurs focused on developing better treatment options for patients. TCG X has investment teams in Palo Alto and New York City

